pharmaphorum

MAY 4, 2021

The life sciences history industry has some unique challenges when it comes to compliance. Early life science pioneers in foreign markets earned a reputation for lax ethical behaviour, making them a prime target for regulators. No excuses. Get control back.

Life Science 109

Life Science Compliance Regulation Marketing 109

Outsourcing Pharma

OCTOBER 5, 2023

A female leadership program has been launched in Denmark by WiLD (Women in Life Science Denmark) for those working in life sciences in Denmark.

Life Science 89

Life Science Regulation Marketing 89

BioPharma Reporter

JULY 10, 2023

Inspired Thinking Group (ITG) the technology-led multichannel marketing activation business, has launched ITG Health to deliver an âautomation-first approachâ to the life sciences industry.

Life Science 52

Life Science Marketing Regulation 52

Outsourcing Pharma

JUNE 7, 2023

With generative AI continuing to create a buzz, OSP took the opportunity to speak to Indegene, a digital-first, life sciences commercialization company that helps biopharmaceutical, emerging biotech and medical device companies develop products.

Life Science 80

Life Science Production Development Regulation 80

XTalks

DECEMBER 29, 2022

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

Outsourcing Pharma

OCTOBER 19, 2023

The Gen AI revolution promises to redefine various industries, with the life sciences sector at the forefront of this transformation. OSP had the chance to speak to Tarun Mathur, CEO at Indegene, who was keen to allay many of the fears those in the industry may have.

Life Science 64

Life Science Regulation Marketing 64

BioPharma Reporter

MAY 17, 2021

Many turn to Boston and North Carolinaâs Research Triangle to set up life science companies, but Chicago is now also fast becoming a draw in this respect. The city is emerging as a life science and biopharma hub and seems poised for even further growth, in CGT in particular.

Life Science 95

Life Science Research Regulation Marketing 95

pharmaphorum

MARCH 12, 2021

If the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed at which vaccines for COVID-19 were discovered, developed, trialled, approved and manufactured have confirmed just how dynamic the industry can be. Building the data-powered life sciences business .

Life Science 109

Life Science Regulation Genome Genomics 109

Pharma Marketing Network

APRIL 21, 2021

The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Sales and Marketing Oversight – April 21, 2021. Darshan Kulkarni and Marc Banjak, General Counsel at Dova Pharmaceuticals, discuss sales compliance in the life sciences.

Sales 90

Sales Marketing Life Science Compliance 90

BioPharma Reporter

NOVEMBER 10, 2021

A new specialized lab, office and collaboration space for over 100 life science and health technology professionals, entrepreneurs, and researchers was recently announced for The Campus, Cherrywood in South Dublin, Ireland.

Life Science 98

Life Science Research Regulation Marketing 98

FDA Law Blog

NOVEMBER 6, 2023

is pleased to announce it took top honors in two categories in the 2023 LMG Life Sciences Awards, which recognize the best life science practitioners and firms over the past 12 months from the United States, Canada, and Europe. life sciences industry. WASHINGTON, DC — Hyman, Phelps & McNamara, P.C.

Life Science 40

Life Science Cosmetics Regulation Drugs 40

pharmaphorum

AUGUST 17, 2022

The latest life science competitiveness indicators (LSCIs) were published by the Office of Life Sciences (OLS) in July 2022. The life sciences ecosystem. The median number of days between marketing authorisation and medicines being made available is included too. Interest in indicators.

Life Science 57

Life Science Medicine Marketing Regulation 57

XTalks

JANUARY 4, 2023

In the era of increasing awareness of environmental, social and governance (ESG) policies, life science companies are starting to take notice of their benefits. ESG policies can be advantageous for small to mid-sized business-to-business (B2B) life science companies in a number of ways. Conclusion.

Life Science 52

Life Science Branding Marketing Regulation 52

pharmaphorum

DECEMBER 9, 2021

If the UK creates regulatory frameworks that drastically diverge from those of its “science allies”, it could become a late – or even no – launch market for new treatments. The same principle applies to regulation,” she went on. ” Prerequisites for global competitiveness. .

Regulation 95

Regulation Medicine Life Science Development 95

pharmaphorum

AUGUST 17, 2020

N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. Engagement channels. Joanna Carlish.

Regulation 90

Regulation Marketing Sales Branding 90

pharmaphorum

JUNE 10, 2022

If you work in pharma, the chances are you’re no stranger to the United States Food and Drug Administration, or FDA, which regulates pharmaceuticals. While the FDA is responsible for regulating both drugs and devices, they’re handled through completely different processes in different parts of the agency.

Regulation 132

Regulation Production Life Science Drugs 132

XTalks

JANUARY 9, 2024

Swoop , a leader in healthcare marketing, recently introduced a groundbreaking portfolio of predictive AI targeting for pharmaceutical and life sciences advertisers. This capability will usher in a new era in healthcare marketing, moving beyond traditional methods that rely on past data to a future-focused approach.

Marketing 104

Marketing Life Science Compliance Doctors 104

FDA Law Blog

SEPTEMBER 26, 2023

HP&M), a leader in providing legal and regulatory support to the life sciences industries, today announced the appointment of Jeff Grizzel to the newly created position of Chief Marketing Officer (CMO). Hyman, Phelps & McNamara, P.C. (HP&M),

Marketing 59

Marketing Life Science Compliance Business Development 59

Pharma in Brief

DECEMBER 3, 2023

This year marks the 30-year anniversary of the Patented Medicines (Notice of Compliance) Regulations ( Regulations ), introduced in 1993 to prevent patent infringement by linking the regulatory approval of generic or biosimilar drugs with the patent rights of innovators. Evolution of the Regulations Coming into force (1993–1997).

Regulation 52

Regulation Compliance Medicine Manufacturing 52

pharmaphorum

JANUARY 10, 2023

Data is transforming life sciences, but many organisations are not using its full potential. Life sciences and the pharmaceutical industry are awash with data. Capturing market share. The combination of health and data, he passionately believes, will transform life sciences.

Marketing 98

Marketing Life Science Sales Branding 98

Outsourcing Pharma

JANUARY 29, 2024

The Pistoia Alliance has published its Identification of Medicinal Products (IDMP) Ontology 1.0 under an open-source license.

Life Science 92

Life Science Licensing Licensing Medicine 92

XTalks

MAY 18, 2023

Gillian Woollett, VP, Head of Regulatory Strategy and Policy at Samsung Bioepis, about the challenges of bring biosimilars to market. Sarah and Dr. Woollett also discuss Samsung Bioepis’ first US Biosimilar Market Report (linked below) and some of its key findings on biosimilar cost savings, uptake and market share.

Life Science 52

Life Science Marketing Development Medicine 52

XTalks

JULY 5, 2022

Employee retention and motivation is a challenge that all life science companies face. A corporate compliance training program is a part of many onboarding programs to ensure employees are up to date with the latest rules and regulations they must adhere to while working for the company.

Life Science 52

Life Science Compliance Packaging Packaging 52

Pharma in Brief

AUGUST 9, 2021

On July 31, 2021, Health Canada published a Notice of Intent outlining its plan to amend the Food and Drug Regulations ( FDR ) and the Medical Devices Regulations in the spring of 2022. Health Canada is accepting comments on the Minister of Health’s proposal to amend the FDR and the Medical Devices Regulations until October 28, 2021.

Regulation 98

Regulation Drugs Manufacturing Production 98

Outsourcing Pharma

MARCH 21, 2024

Merck set to invest over â300 million in new production center in South Korea.

Life Science 77

Life Science Production Regulation Marketing 77

Drug Discovery World

MARCH 30, 2023

Likang Life Sciences has been granted implied approval by China’s National Medical Products Administration (NMPA) for the clinical trial of its innovative personalised neoantigen-targeted vaccine LK101 Injection for advanced solid tumours. Hence, there is a need to increase clinical investigations in this promising area.”

Regulation 52

Regulation Vaccination Vaccine Trials 52

pharmaphorum

DECEMBER 14, 2021

The first publication focused on market and patient access, whereas the new report concentrates on the final part of the route to marketing authorisation: from the final scientific opinion of the Committee for Medicinal Products for Human Use (CHMP) to the final decision of the European Commission (EC). Tide of change.

Regulation 74

Regulation Marketing Life Science Medicine 74

Outsourcing Pharma

MARCH 25, 2021

A survey by the Pistoia Alliance indicates most professionals believe the tech can accelerate R&D, but companies are stymied by a skills gap and data bias.

Life Science 145

Life Science Regulation Marketing 145

Pharmaceutical Commerce

JULY 27, 2023

Drug safety database can now be used by life sciences organizations that are looking to develop, manufacture, and market regulated products in the country.

Life Science 52

Life Science Regulation Manufacturing Production 52

Outsourcing Pharma

FEBRUARY 5, 2024

Life sciences technology company ArisGlobal, has announced the formal charter for the new generative AI Council, which will sit for the first time this month in a bid to advance life sciences innovation.

Life Science 88

Life Science Regulation Marketing 88

BioPharma Reporter

MARCH 21, 2024

AstraZeneca recently announced its Â650 million investment in the UK, held up by Chancellor Jeremy Hunt as a âvote of confidenceâ in the countryâs life sciences sector.

Life Science 97

Life Science Regulation Marketing 97

pharmaphorum

JULY 19, 2021

A new report published by Medicines Discovery Catapult and CPI details the huge medical and market potential for complex medicines in the UK. Over 50% identified a better understanding of complex medicines by regulators as key to developing this field. Click here to read the full report.

Life Science 52

Life Science Medicine RNA Vaccination 52

Pharma in Brief

MAY 4, 2023

The Ontario Superior Court ( ONSC ) has dismissed a claim for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the Regulations ) brought by Apotex Inc. The Court conducted a purposive interpretation of the Regulations and found that Apotex did not meet the statutory requirements for damages.

Regulation 52

Regulation Sales Production Compliance 52

pharmaphorum

MAY 6, 2022

For life science companies around the world, enabling faster access to innovative drugs and therapies is a complicated challenge. With key industry players under scrutiny from trade regulators, a new wave of ePrescribing companies have begun to emerge in the US. Read Deep Dive: Market Access in full.

Marketing 52

Marketing Life Science Regulation Development 52

BioPharma Reporter

JANUARY 3, 2024

Gilda DâIncerti is CEO and founder of PQE Group, a life science consulting company, and she likes her company to work like a small English village where everyone knows each other.

Life Science 119

Life Science Regulation Marketing 119

Drug Discovery World

FEBRUARY 12, 2024

“In the upcoming year, we will see the expansion of new, more complex markets and updated requirements from regulators. The challenge is harnessing the power of AI within a highly regulated industry. The key challenge for all regulators next year is ensuring that they can keep up with the progress of the technology.”

Genome 139

Genome Genomics Life Science Gene Therapy 139

Pharma in Brief

DECEMBER 8, 2022

The New Mandatory Factors, which required the Board to consider pharmacoeconomic value, market size, and Gross Domestic Product when determining whether the price of a medicine was “excessive”. The FCA rejects a hyperdeferential standard of review for regulations. The FCA affirms statutory limits on the PMPRB.

Regulation 52

Regulation Medicine Life Science Production 52